FORMISANO, LUIGI
 Distribuzione geografica
Continente #
EU - Europa 18
AS - Asia 8
NA - Nord America 6
SA - Sud America 2
Totale 34
Nazione #
IT - Italia 14
VN - Vietnam 8
US - Stati Uniti d'America 6
IE - Irlanda 3
EC - Ecuador 2
PT - Portogallo 1
Totale 34
Città #
Dong Ket 8
Napoli 6
Ferrara 2
Formia 2
Sangolqui 2
Ann Arbor 1
Council Bluffs 1
Massafra 1
Mountain View 1
Naples 1
New York 1
Pisa 1
Rome 1
Setúbal 1
Totale 29
Nome #
A Phase Ib Study of Alpelisib (BYL719), a PI3Ka-Specific Inhibitor, with Letrozole in ERþ/HER2 Metastatic Breast Cancer, file e268a732-a049-4c8f-e053-1705fe0a812c 8
Kinome-wide RNA interference screen reveals a role for PDK1 in acquired resistance to CDK4/6 inhibition in ER-positive breast cancer, file e268a732-da33-4c8f-e053-1705fe0a812c 8
Hedgehog signalling pathway orchestrates angiogenesis in triple-negative breast cancers, file e268a732-d46e-4c8f-e053-1705fe0a812c 6
Impact of a cardio-oncology unit on prevention of cardiovascular events in cancer patients, file e268a733-67f7-4c8f-e053-1705fe0a812c 6
Association of FGFR1 with ERαmaintains ligand-independent ER transcription and mediates resistance to estrogen deprivation in ER+ breast cancer, file e268a732-d46c-4c8f-e053-1705fe0a812c 3
SPHINGOSINE KINASE 1 (SPHK1) CONTRIBUTES TO RESISTANCE TO EPIDERMAL GROWTH FACTOR RECEPTOR (EGFR) INHIBITORS IN COLORECTAL CANCER MODELS, file e268a72c-d2ac-4c8f-e053-1705fe0a812c 2
Combined Blockade of Activating ERBB2 Mutations and ER Results in Synthetic Lethality of ER+/HER2 Mutant Breast Cancer., file e268a732-c6d7-4c8f-e053-1705fe0a812c 1
Totale 34
Categoria #
all - tutte 95
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 95


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202110 0000 00 00 6004
2021/202211 4000 00 00 4030
2022/202313 0012 02 16 1000
Totale 34